Biology Reference
In-Depth Information
Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. 1997. Human killer cell
activatory receptors for MHC class I molecules are included in a multimeric complex expressed
by natural killer cells. J Immunol 158: 5083±5086.
Oyaizu N, et al. 1995. Mechanisms of apoptosis in peripheral blood mononuclear cells of HIV-
infected patients. In: Audrieu J-M, Lu W (eds). Cell Activation and Apoptosis of HIV-Infection.
New York, Plenum Press, pp 101±114.
Plaeger-Marshall S, Spina CA, Giorgi JV, Mitsuyasu R, Wolfe P, Gottlieb M, Beall G. 1987.
Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune de®-
ciency syndrome (AIDS). J Clin Immunol 7: 16±23.
Poggi A, Minagari MC. 1995. Development of human NK cells from the immature cell precursors.
Semin Immunol 7: 61±66.
Prati E, Gorla R, Malacarne F, Airo P, Brugnoni D, Gargiulo F, Tebaldi A, Castelli F, Carosi G,
Cattaneo R. 1997. Study of spontaneous apoptosis in HIV
patients: correlation with clinical
progression and T cell loss. AIDS Res Hum Retroviruses 13: 1501±1508.
Raulet DH, Correa I, Corral L, Dorfman J, Wu MF. 1995. Inhibitory e¨ects of class I molecules on
murine NK cells: speculations on function, speci®city and self-tolerance. Semin Immunol 7: 103±
107.
Rollins BJ. 1997. Chemokines. Blood 90: 909±928.
Saksela K. 1997. HIV-1 Nef and host cell protein kinases. Front Biosci 2: 606±618.
Samuelsson A, Brostrom C, van Dijk N, Sonnerborg A, Chiodi F. 1997. Apoptosis of CD4
and
CD19
cells during human immunode®ciency virus type1 infectionÐcorrelation with clinical
progression, viral load, and loss of humoral immunity. Virology 238: 180±188.
Sanchez M, Spits H, Lanier LL, Phillips JH. 1993. Human natural killer cell committed thymocytes
and their relation to the T cell lineage. J Exp Med 178: 1857±1866.
Sepulveda C, Puente J, Weinstein C, Wolf ME, Mosnaim AD. 1997. Enhancement of natural killer
cell activity in HIV-1-infected subjects by a mixture of the calcium ionophore A23187 and the
phorbol ester TPA: lack of response to a similar challenge with interleukin-2 or alpha-interferon.
Am J Ther 4: 413±421.
Shephard RJ. 1998. Exercise, immune function and HIV infection. J Sports Med Phys Fitness 38:
101±110.
Shi L, Kraut RP, Aebersold R, Greenberg AH. 1992. A natural killer cell granule protein that in-
duces DNA fragmentation and apoptosis. J Exp Med 175: 553±566.
Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M,
Young F, Stall AM. 1992. RAG-2-de®cient mice lack mature lymphocytes owing to inability to
initiate V( D)J rearrangement. Cell 68: 855±867.
Sirianni MC, Soddu S, Malorni W, Arancia G, Aiuti F, Soddus S. 1988. Mechanism of defective
natural killer cell activity in patients with AIDS is associated with defective distribution of
tubulin. J Immunol 140: 2565±2568.
Skowron G, Cole BF, Zheng D, Accetta G, Yen-Lieberman B. 1997. gp120-directed antibody-
dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage
in HIV-1 disease. AIDS 11: 1807±1814.
Tanneau F, McChesney M, Lopez O, Sansonetti P, Montagnier L, Riviere Y. 1990. Primary cyto-
toxicity against the envelope glycoprotein of human immunode®ciency virus-1: evidence for
antibody-dependent cellular cytotoxicity in vivo. J Infect Dis 162: 837±843.
Taub DD, Sayers TJ, Carter CR, Ortaldo JR. 1995. Alpha and beta chemokines induce NK cell
migration and enhance NK-mediated cytolysis. J Immunol 155: 3877±3888.
Tomasello E, Olcese L, Vely F, Geourgeon C, Blery M, Moqrich A, Gautheret D, Djabali M,
Mattei MG, Vivier E. 1998. Gene structure, expression pattern, and biological activity of mouse
killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem 273: 34115±
34119.
